Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16502-01-5

Post Buying Request

16502-01-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16502-01-5 Usage

Description

1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole is a heterocyclic organic compound with a unique structure that features a pyridoindole framework. It is a tan solid and has been the subject of research for its potential applications in various fields, particularly in the study of neurodegenerative diseases and as a mitotic kinesin inhibitor for anti-cancer properties.

Uses

Used in Pharmaceutical Industry:
1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole is used as a mitotic kinesin inhibitor for its potential as a novel anti-cancer agent. It targets the mitotic kinesin proteins, which play a crucial role in cell division, thereby inhibiting the proliferation of cancer cells.
Used in Neurodegenerative Disease Research:
1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole is used in the study of neurodegenerative diseases to understand its potential role in the development of therapeutic agents. Its unique structure and properties make it a promising candidate for investigating its effects on neurodegenerative conditions.
Used in Chemical Research:
The ozonolysis of the enamine bond of 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole derivatives has been studied, providing insights into the chemical properties and potential applications of this compound in various chemical processes.

Check Digit Verification of cas no

The CAS Registry Mumber 16502-01-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,5,0 and 2 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 16502-01:
(7*1)+(6*6)+(5*5)+(4*0)+(3*2)+(2*0)+(1*1)=75
75 % 10 = 5
So 16502-01-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H12N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-4,12-13H,5-7H2

16502-01-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (300764)  1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole  98%

  • 16502-01-5

  • 300764-1G

  • 581.49CNY

  • Detail
  • Aldrich

  • (300764)  1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole  98%

  • 16502-01-5

  • 300764-5G

  • 1,987.83CNY

  • Detail

16502-01-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,2,3,4-TETRAHYDRO-9H-PYRIDO[3,4-B]INDOLE

1.2 Other means of identification

Product number -
Other names 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16502-01-5 SDS

16502-01-5Relevant articles and documents

An insight into tetrahydro-β-carboline-tetrazole hybrids: Synthesis and bioevaluation as potent antileishmanial agents

Purohit, Pooja,Pandey, Anand Kumar,Singh, Deepti,Chouhan, Pradeep Singh,Ramalingam, Karthik,Shukla, Mahendra,Goyal, Neena,Lal, Jawahar,Chauhan, Prem M. S.

, p. 1824 - 1834 (2017)

A series of 2,3,4,9-tetrahydro-β-carboline tetrazole derivatives (14a-u) have been synthesized utilizing the Ugi multicomponent reaction and were identified as potential antileishmanial chemotypes. Most of the screened derivatives exhibited significant in vitro activity against the promastigote (IC50 from 0.59 ± 0.35 to 31 ± 1.27 μM) and intracellular amastigote forms (IC50 from 1.57 ± 0.12 to 17.6 ± 0.2 μM) of L. donovani, and their activity is comparable with standard drugs miltefosine and sodium stibogluconate. The most active compound 14t was further studied in vivo against the L. donovani/golden hamster model at a dose of 50 mg kg-1 through the intraperitoneal route for 5 consecutive days, which displayed 75.04 ± 7.28% inhibition of splenic parasite burden. Pharmacokinetics of compound 14t was studied in the golden Syrian hamster, and following a 50 mg kg-1 oral dose, the compound was detected in hamster serum for up to 24 h. It exhibited a large volume of distribution (651.8 L kg-1), high clearance (43.2 L h-1 kg-1) and long mean residence time (10 h).

Synthesis of C-14-labeled novel IKK inhibitor: 2-[14C]-N-(6- chloro-9H-pyrido [3,4-b]indol-8-yl)-3-pyridinecarboxamide

Li, Yuexian,Prakash, Shimoga R.

, p. 323 - 330 (2005)

2-[14C]-N-(6-Chloro-9H-pyrido [3,4-b]indol-8-yl)-3- pyridinecarboxamide (9A, also referred to as [14C]-PS-1145) was synthesized from [14C]-paraformaldehyde in five steps in an overall radiochemical yield of 15%. The key intermediate 1-[14C]-6-chloro-1, 2,3,4-tetrahydro-β-carboline was obtained by Pictet-Spengler cyclization of chlorotryptamine with [14C]-paraformaldehyde. Similar reactions were conducted with tryptamine to address the generality of the methodology. Copyright

Visible-Light-Mediated Synthesis of Rutaecarpine Alkaloids through C-N Cross-Coupling Reaction

Chen, Dong,Li, Shiqing,Wang, Jinhua,Gou, Tiantian,Zhang, Linfeng,Wang, Guixia,Kong, Xiangfei

, p. 987 - 992 (2021)

A visible-light-initiated cross-dehydrogenative-coupling amination is described, featuring metal- and photocatalyst-free, at room temperature, and using air as an oxidant. The reaction provides a facile approach for the synthesis of rutaecarpine and its derivatives. The substrates with electron-withdrawing groups give higher yields than those with electron-donating groups, but the substituent position has a negligible influence on the yield. Using binaphthyl-diyl hydrogen phosphate and dibenzyl phosphate as catalysts both deliver satisfying yields. This straightforward light-driven strategy might be applicable to the synthesis of quinazolinone derivatives.

Using Methanol as a Formaldehyde Surrogate for Sustainable Synthesis of N-Heterocycles via Manganese-Catalyzed Dehydrogenative Cyclization

Li, Yibiao,Liu, Qiang,Shao, Zhihui,Yuan, Shanshan

supporting information, (2022/02/23)

The development of an efficient and sustainable synthetic route for formaldehyde production from renewable feedstock, especially in combination with a subsequent transformation to straightforwardly construct valuable chemicals, is highly desirable. Herein, we report a novel manganese-catalyzed dehydrogenative cyclization of methanol as a formaldehyde surrogate with a variety of dinucleophiles for facile synthesis of N-heterocycles. The in situ generated formaldehyde via catalytic methanol dehydrogenation can be selectively trapped by diverse dinucleophiles to avoid several possible side reactions. The utility of this transformation is further highlighted by its successful application to the synthesis of 13C-labeled N-heterocycles using 13CH3OH as a readily accessible 13C-isotope reagent.

TCCA-mediated oxidative rearrangement of tetrahydro-β-carbolines: Facile access to spirooxindoles and the total synthesis of (±)-coerulescine and (±)-horsfiline

Sathish, Manda,Sakla, Akash P.,Nachtigall, Fabiane M.,Santos, Leonardo S.,Shankaraiah, Nagula

, p. 16537 - 16546 (2021/05/19)

Multi-reactive centered reagents are beneficial in chemical synthesis due to their advantage of minimal material utilization and formation of less by-products. Trichloroisocyanuric acid (TCCA), a reagent with three reactive centers, was employed in the synthesis of spirooxindoles through the oxidative rearrangement of various N-protected tetrahydro-β-carbolines. In this protocol, low equivalents of TCCA were required to access spirooxindoles (up to 99% yield) with a wide substrate scope. Furthermore, the applicability and robustness of this protocol were proven for the gram-scale total synthesis of natural alkaloids such as (±)-coerulescine (1) and (±)-horsfiline (2) in excellent yields.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16502-01-5